These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990 [TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis: activation of the injured vessel wall. Gotlieb AI; Wong MK Cardiovasc Clin; 1988; 18(2):3-21. PubMed ID: 3275417 [No Abstract] [Full Text] [Related]
10. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Cox DA; Cohen ML Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Norata GD; Tonti L; Roma P; Catapano AL Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):297-305. PubMed ID: 12616810 [TBL] [Abstract][Full Text] [Related]
12. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Barlic J; Zhang Y; Foley JF; Murphy PM Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772 [TBL] [Abstract][Full Text] [Related]
13. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Hakala JK; Oksjoki R; Laine P; Du H; Grabowski GA; Kovanen PT; Pentikäinen MO Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1430-6. PubMed ID: 12750117 [TBL] [Abstract][Full Text] [Related]
14. [Lipoproteins, antioxidants, and coronary cardiopathy]. Guimarães AC Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520 [No Abstract] [Full Text] [Related]
15. [The role of immune inflammation in atherogenesis]. Nagornev VA; Rabinovich VS Vopr Med Khim; 1997; 43(5):339-48. PubMed ID: 9446324 [TBL] [Abstract][Full Text] [Related]
16. [Macro- and micropathology of coronary vessels]. Mall G; Siemens I; Zimmermann R Verh Dtsch Ges Inn Med; 1991; 97():85-91. PubMed ID: 1808958 [No Abstract] [Full Text] [Related]
17. Arteriosclerosis in transplanted hearts: too much and too soon. Libby P; Pober JS; Swanson SJ; Mudge GH; Schoen FJ Can J Cardiol; 1991 Apr; 7(3):XI-XII. PubMed ID: 2044011 [No Abstract] [Full Text] [Related]
18. [New information on the pathophysiology of atherosclerosis]. Reiner Z; Tedeschi-Reiner E Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194 [TBL] [Abstract][Full Text] [Related]
19. Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity. Choy JC; McDonald PC; Suarez AC; Hung VH; Wilson JE; McManus BM; Granville DJ Mod Pathol; 2003 May; 16(5):460-70. PubMed ID: 12748253 [TBL] [Abstract][Full Text] [Related]
20. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches. Rabinovitch M; Molossi S; Clausell N J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473 [No Abstract] [Full Text] [Related] [Next] [New Search]